T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes

Diabetes

Volumn 48, Issue 9, 1999, Pages 1794-1800

  Oku, Akira ^a   Ueta, Kiichiro ^a   Arakawa, Kenji ^a   Ishihara, Tomomi ^a   Nawano, Masao ^a   Kuronuma, Yasno ^a   Matsumoto, Mamoru ^a   Saito, Akira ^a   Tsujihara, Kenji ^a   Anai, Motonobu ^b   Asano, Tomoichiro ^b   Kanai, Yoshikatsu ^c   Endou, Hitoshi ^c  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (5 BENZOFURANYL) 1 [2 HYDROXY 6 [6 O (METHOXYCARBONYL) BETA DEXTRO GLUCOPYRANOSYL] 4 METHYLPHENYL] 1 PROPANONE; ANTIDIABETIC AGENT; CARRIER PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER; HEMOGLOBIN A1C; PHLORIZIN; PHLORIZIN DERIVATIVE; STREPTOZOCIN; T 1095A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DOG; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSURIA; HUMAN; HUMAN CELL; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; KIDNEY TUBULE ABSORPTION; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT; STREPTOZOCIN DIABETES; XENOPUS;

ADMINISTRATION, ORAL; ANIMALS; CARBONATES; DIABETES MELLITUS, EXPERIMENTAL; DOGS; GLUCOSE; GLUCOSIDES; HUMANS; KIDNEY; MALE; MICE; MONOSACCHARIDE TRANSPORT PROTEINS; POSTPRANDIAL PERIOD; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; XENOPUS;

EID: 0032850016     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.9.1794     Document Type: Article

References (29)

1. Leahy J, Bonner-Weir S, Weir G: β-cell dysfunction induced by chronic hyperglycemia: current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442-455, 1992
2. Rossetti L, Giaccari A, DeFronzo R: Glucose toxicity. Diabetes Care 13: 610-630, 1990
3. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
4. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-993, 1995
5. The Diabetes Control and Complications Trial Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47: 1703-1720, 1995
6. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy in the Diabetes Control and Complications Trial. Ann Intern Med 122: 561-568, 1995
7. Silverman M, Turner RJ: Glucose transport in the renal proximal tubule. In Handbook of Physiology. Section 8: Renal Physiology. Vol. 2. Windhager EE, Ed. Oxford, U.K., Oxford University Press, 1992, p. 2017-2038
8. Silverman M: Structure and function of hexose transporters. Annu Rev Biochem 60:757-794, 1991
9. Deepen P, Baeyer HV, Drexel H: Renal handling of D-glucose and other sugars. In Textbook of Nephrology. Vol. 1, 3rd ed. Massry SG, Glassock RJ, Eds. Baltimore, Williams & Wilkins, 1995, p. 90-94
10. +/proline cotransporters. Proc Natl Acad Sci U S A 86:5748-5752, 1989
11. +/glucose cotransporter reevaluation of function and distribution of expression. J Biol Chem 269:12032-12039, 1994
12. +/glucose cotransporter. Nature 330:379-381, 1987
13. Ohta T, Isselbacher KJ, Rhoads DB: Regulation of glucose transporters in LLC-PK1 cells: effects of D-glucose and monosaccharides. Mol Cell Biol 10: 6491-6499, 1990
14. Wells RG, Pajor AM, Kanai Y, Turk E, Wright EM, Hediger MA: Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter. Am J Physiol 263:F459-F465, 1992
15. You G, Lee WS, Barros EJ, Kanai Y, Huo TL, Khawaja S, Wells RG, Nigam SK, Hediger MA: Molecular characteristics of Na(+)-coupled glucose transporters in adult and embryonic rat kidney. J Biol Chem 270:29365-29371, 1995
16. +/glucose cotransporter SGLT2: delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest 93:397-404, 1994
17. +/glucose cotransporters. J Biol Chem 268:1509-1512, 1993
18. +/glucose cotransporter and not an amino acid transporter. J Biol Chem 269:22488-22491, 1994
19. Hediger MA, Kanai Y, You G, Nussberger S: Mammalian ion-coupled solute transporters. J Physiol 482:7S-14S, 1995
20. Blondel O, Bailbe D, Portha B: Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment. Metabolism 39:787-797, 1990
21. Khan A, Efendic S: Evidence that increased glucose cycling in islets of diabetic ob/ob mice is a primary feature of the disease. Am J Physiol 269:E623-E626, 1995
22. Krook A, Kawano Y, Song XM, Efendic S, Roth RA, Wallberg-Henriksson H, Zierath JR: Improved glucose tolerance restores insulin-stimulated Akt Kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 46:2110-2114, 1997
23. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
24. Lisato G, Cusin I, Tiengo A, Prato SD, Jeanrenaud B: The contribution of hyperglycemia and hypoinsulinaemia to the insulin resistance of streptozotocindiabetic rats. Diabetologia 35:310-315, 1992
25. Malathi P, Preisher H, Fairclough P, Mallett P, Crane RK: A rapid method for the isolation of kidney brush border membranes. Biochim Biophys Acta 554:259-263, 1979
26. Iwatsuka H, Shino A, Suzuoki Z: General survey of diabetic features of yellow KK mouse. Endocrinol Jpn 17:25-35, 1970
27. Lotspeich WD: Phlorizin and the cellular transport of glucose. Harvey Lect 56:63-91, 1961
28. +-glucose cotransporter as antidiabetic agents. III. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives modified at the OH groups of the glucose moiety. Chem Pharm Bull 46: 1545-1555, 1998
29. American Diabetes Association: Implications of the Diabetes Control and Complications Trial. Diabetes Care 16:1517-1520, 1993